We are live on ! Find out more
MBOT icon

Microbot Medical

34 hedge funds and large institutions have $3.94M invested in Microbot Medical in 2015 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 4

100% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 4

13% more funds holding

Funds holding: 3034 (+4)

24% less capital invested

Capital invested by funds: $5.19M → $3.94M (-$1.25M)

Holders
34
Holders Change
+4
Holders Change %
+13.33%
% of All Funds
0.95%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
10
Reduced
4
Closed
4
Calls
Puts
Net Calls
Net Calls Change

MBOT Hedge Fund Activity: Q3 2015 in Review

34 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2015, worth a combined $3.94M — down 24% from $5.19M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new MBOT positions and 4 closed out — a net gain of 4 holders — while 10 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $45.6K. The largest seller was Virtu KCG Holdings, cutting an estimated $61.5K.

  • 34 institutional investors held Microbot Medical (MBOT) as of Q3 2015, up from 30 in Q2 2015.
  • Funds reported $3.94M of Microbot Medical stock for Q3 2015, down 24% quarter-over-quarter.
  • 8 funds opened new Microbot Medical positions in Q3 2015 and 4 closed out, a net change of +4 holders.
  • The largest Microbot Medical buyer in Q3 2015 was Renaissance Technologies, an estimated $45.6K added.
  • The largest Microbot Medical seller in Q3 2015 was Virtu KCG Holdings, an estimated $61.5K sold.

Based on aggregated 13F filings for Q3 2015.